<DOC>
	<DOCNO>NCT02992496</DOCNO>
	<brief_summary>The purpose double-blind , control , randomize study investigate antidepressant efficacy oral ketamine treatment patient suffer major depressive episode .</brief_summary>
	<brief_title>Investigation Antidepressant Efficacy Oral Ketamine Treatment</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Diagnosis major depressive episode scope major depressive bipolar disorder support Structured Clinical Interview DSMIVTR ( SCID ) Hamilton depression rating scale score â‰¥ 19 Willingness competence sign inform consent form Stable psychopharmacological treatment 10 day ( except benzodiazepine ) Initiation new antidepressant mood stabilize treatment ( pharmacological , physical psychotherapeutic ) adequate dosage ( define minimum recommend dose respective prescribe information ) within 4 week prior inclusion Prior use ketamine Pregnancy/Breast feeding Instable arterial hypertension &gt; 170/110mmHg Hepatic dysfunction Hyperthyreosis History glaucoma Neurodegenerative disorder Any unstable medical illness History substance abuse within past 12 month History psychosis Failure comply study protocol follow instruction investigate team Current treatment one follow drug : clopidogrel , carbamazepine , valproate , barbiturate , memantine , modafinil , disulfiram , amiodarone , ranolazine , phenytoin , verapamil , fibrates , antiretroviral agent , antimicrobial chemotherapeutics , azole antifungal , glucocorticoid , cyclosporine , valeriana/garlic/grapefruit preparation , St. John 's wort .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>